Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Research Article
Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian
Seyed Alavian*,
Behzad Hajarizadeh,
Bashir Hajibeigi,
Taher Doroudi,
Amir Hamadanizadeh,
Koroush Abar
Case Report
Hearing Loss as a Complication of Peginterferon Alfa 2a Combination Therapy in a Patient with Hepatitis C Virus Infection
Mohssen Toosi*,
Mohammad Hassanabadi
Research Article
The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial
Nasser Daryani*,
Babak Haghpanah,
Ali Sayyah,
Ali Hashtroudi,
Mohammad Bashashati,
Parisa Poursamimi
,et al.Letter
Amantadine therapy for chronic hepatitis C: a dose escalation study
Smith JP,
Riley 3rd,
Bingaman S,
Mauger DT,
Shahram Mirmomen*
Research Article
Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C
Mohammad Zali*,
Hamid Shalmani,
Mohsen Norouzinia,
Amir MohammadAlizadeh,
Azita Nowroozi,
Negar Behrouz
Letter
A multicentre study of the usefulness of liuer biopsy in hepatitis [ J Uiral Hep 2004 July; 11 (4): 375
Seyed Alavian
*,
*,Sbahram Mirmomen,
V:G:Bain ,
M Bonacini,
S Govindarajan,
M Ma
,et al.Research Article
The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia
Shahram Mirmomen*,
Naser Daryani,
Reza Malekzadeh,
Mohammad Zali,
Babak Haghpanah,
Parisa Poursamimi
,et al.Research Article
Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C and Inherited Bleeding Disorders
Shahin Merat,
Amir Sohrabpour,
Siamak Khaleghi,
Masoud Sohrabi,
Katayon Rad,
Amir Radmard
,et al.
.png){kind=logo}